ImaginAb launching clinical trial for renal cancer and malignant melanoma
ImaginAb Inc., which is focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and…
December 6, 2022 - 3 minutes
News and Trends
Positive results from BioAge muscle atrophy trial
BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective,…
December 6, 2022 - 4 minutes
Startup Graegis developing therapies for radiation side-effects
Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies,…
December 6, 2022 - 2 minutes
Positive antibody persistence for vaccine treating mosquito disease
A single shot vaccine for mosquito-borne disease chikungunya has had positive antibody persistence data 12…
December 5, 2022 - 3 minutes
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is…
December 5, 2022 - 3 minutes
New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose…
December 5, 2022 - 3 minutes
Singapore researchers develop affordable cancer testing method
Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of…
December 5, 2022 - 4 minutes
Bactobio raises £6M to search for new antimicrobials
U.K. biotech company Bactobio Ltd. has closed an oversubscribed £6 million ($7.4 million) bridge financing…
December 5, 2022 - 2 minutes
MaxCyte and Curamys sign cell and gene therapies agreement
MaxCyte, Inc. and Curamys have announced the signing of a strategic platform license. MaxCyte is…
December 5, 2022 - 2 minutes
Faron Pharmaceuticals provides cancer treatment update
Faron Pharmaceuticals Oy has given an update on its phase I/II BEXMAB study, investigating bexmarilimab.…
December 5, 2022 - 2 minutes
First subject dosed in inflammation phase I study
Innovent Biologics, Inc. and UNION therapeutics A/S have announced that the first Chinese healthy volunteer…
December 5, 2022 - 5 minutes
Kintor Pharma says alopecia primary endpoint met
Kintor Pharmaceutical Limited has announced results of a phase II clinical trial of pyrilutamide (KX-826),…
December 5, 2022 - 3 minutes
